Larimar Therapeutics
LRMR
#8193
Rank
NZ$0.35 B
Marketcap
$5.56
Share price
-2.45%
Change (1 day)
-71.46%
Change (1 year)

EPS for Larimar Therapeutics (LRMR)

EPS in 2023 (TTM): -$1.53

According to Larimar Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.60. In 2022 the company made an earnings per share (EPS) of -$2.68 an increase over its 2021 EPS that were of -$5.17.

EPS history for Larimar Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.53-43.04%
2022-$2.68-48.15%
2021-$5.17-14.27%
2020-$6.03